Patents by Inventor Scott Crist

Scott Crist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating bladder tumor cells using fibronectin attachment protein as a target
    Patent number: 9861707
    Abstract: Composition and methods are disclosed for utilizing microaggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: January 9, 2018
    Assignee: Purdue Research Foundation
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist
  • TREATING BLADDER TUMOR CELLS USING FIBRONECTIN ATTACHMENT PROTEIN AS A TARGET
    Publication number: 20170095568
    Abstract: Composition and methods are disclosed for utilizing microaggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Application
    Filed: December 12, 2016
    Publication date: April 6, 2017
    Inventors: Ruben Claudio AGUILAR, Timothy RATLIFF, David THOMPSON, Scott CRIST
  • Treating bladder tumor cells using fibronectin attachment protein as a target
    Patent number: 9518114
    Abstract: Composition and methods are disclosed for utilizing micro-aggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: December 13, 2016
    Assignee: Purdue Research Foundation
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist
  • TREATING BLADDER TUMOR CELLS USING FIBRONECTIN ATTACHMENT PROTEIN AS A TARGET
    Publication number: 20130230584
    Abstract: Composition and methods are disclosed for utilizing micro-aggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Application
    Filed: November 11, 2011
    Publication date: September 5, 2013
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist